Q2M Biotech AG (HAM:QBI) Debt-to-Equity : 0.00 (As of . 20)

View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Debt-to-Equity?

Q2M Biotech AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was €0.00 Mil. Q2M Biotech AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was €0.00 Mil. Q2M Biotech AG's Total Stockholders Equity for the quarter that ended in . 20 was €0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Q2M Biotech AG's Debt-to-Equity or its related term are showing as below:

HAM:QBI's Debt-to-Equity is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.15
* Ranked among companies with meaningful Debt-to-Equity only.

Q2M Biotech AG Debt-to-Equity Historical Data

The historical data trend for Q2M Biotech AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Debt-to-Equity Chart

Q2M Biotech AG Annual Data

Trend

Debt-to-Equity

Q2M Biotech AG Quarterly Data

Debt-to-Equity

Competitive Comparison of Q2M Biotech AG's Debt-to-Equity

For the Biotechnology subindustry, Q2M Biotech AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Q2M Biotech AG's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q2M Biotech AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Q2M Biotech AG's Debt-to-Equity falls into.

Q2M Biotech AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Q2M Biotech AG's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/	N/A
	=	N/A

Q2M Biotech AG's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/
	=	N/A

Q2M Biotech AG (HAM:QBI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Q2M Biotech AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Q2M Biotech AG (HAM:QBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Haeschenstrasse 17-19, Bremen, DEU

Website

http://

Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines